Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
50.53
-0.25 (-0.49%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Amphastar Pharmaceuticals Revenue
Amphastar Pharmaceuticals had revenue of $182.39M in the quarter ending June 30, 2024, with 25.17% growth. This brings the company's revenue in the last twelve months to $712.89M, up 31.80% year-over-year. In the year 2023, Amphastar Pharmaceuticals had annual revenue of $644.40M with 29.14% growth.
Revenue (ttm)
$712.89M
Revenue Growth
+31.80%
P/S Ratio
3.45
Revenue / Employee
$404,822
Employees
1,761
Market Cap
2.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 644.40M | 145.41M | 29.14% |
Dec 31, 2022 | 498.99M | 61.22M | 13.98% |
Dec 31, 2021 | 437.77M | 87.92M | 25.13% |
Dec 31, 2020 | 349.85M | 27.49M | 8.53% |
Dec 31, 2019 | 322.36M | 27.69M | 9.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Ardent Health Partners | 5.63B |
ACADIA Pharmaceuticals | 890.53M |
GoodRx Holdings | 775.09M |
Inari Medical | 574.50M |
Catalyst Pharmaceuticals | 434.48M |
Twist Bioscience | 295.21M |
Arrowhead Pharmaceuticals | 19.65M |
IDEAYA Biosciences | 11.96M |
AMPH News
- 2 days ago - Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024 - Accesswire
- 4 weeks ago - Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2 - GuruFocus
- 6 weeks ago - Amphastar Pharmaceuticals Offers Interesting Growth And Income Prospects - Seeking Alpha
- 2 months ago - Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference - Accesswire
- 2 months ago - 6 Beaten Down Stocks Rated Buy (SA Quant) - Seeking Alpha
- 2 months ago - Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024 - Accesswire
- 3 months ago - Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024 - Accesswire